Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Among patients with heart failure who have mitral regurgitation due to left ventricular dysfunction, the prognosis is poor. Transcatheter mitral-valve repair may improve their clinical outcomes. METHODS: At 78 sites in the United States and Canada, we enrolled patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy. Patients were randomly assigned to transcatheter mitral-valve repair plus medical therapy (device group) or medical therapy alone (control group). The primary effectiveness end point was all hospitalizations for heart failure within 24 months of follow-up. The primary safety end point was freedom from device-related complications at 12 months; the rate for this end point was compared with a prespecified objective performance goal of 88.0%. RESULTS: Of the 614 patients who were enrolled in the trial, 302 were assigned to the device group and 312 to the control group. The annualized rate of all hospitalizations for heart failure within 24 months was 35.8% per patient-year in the device group as compared with 67.9% per patient-year in the control group (hazard ratio, 0.53; 95% confidence interval [CI], 0.40 to 0.70; P<0.001). The rate of freedom from device-related complications at 12 months was 96.6% (lower 95% confidence limit, 94.8%; P<0.001 for comparison with the performance goal). Death from any cause within 24 months occurred in 29.1% of the patients in the device group as compared with 46.1% in the control group (hazard ratio, 0.62; 95% CI, 0.46 to 0.82; P<0.001). CONCLUSIONS: Among patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy, transcatheter mitral-valve repair resulted in a lower rate of hospitalization for heart failure and lower all-cause mortality within 24 months of follow-up than medical therapy alone. The rate of freedom from device-related complications exceeded a prespecified safety threshold. (Funded by Abbott; COAPT ClinicalTrials.gov number, NCT01626079 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The magnitude of the tirzepatide-mediated improvement in the win ratio was large and similar to the effect of transcatheter mitral valve repair in patients with HF and secondary mitral regurgitation.32”
From Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity (2025) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,044
Self-citation2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Self-citationPercutaneous Repair or Surgery for Mitral Regurgitation
Feldman, T., Foster, E., Glower, D. D., Kar, S., Rinaldi, M. J., Fail, P. S., Smalling, R. W., Siegel, R., Rose, G. A., Engeron, E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009355 · Cited by 2,183
Self-citationThe prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Goldstein, D., Moskowitz, A. J., Gelijns, A. C., Ailawadi, G., Parides, M. K., Perrault, L. P., Hung, J. W., Voisine, P., Dagenais, F., Gillinov, A. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512913 · Cited by 972
Self-citationPercutaneous Mitral Valve Interventions in the Real World
Maisano, F., Franzen, O., Baldus, S., Schäfer, U., Hausleiter, J., Butter, C., Ussia, G. P., Sievert, H., Richardt, G., Widder, J. D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.094 · Cited by 839
Stone, G. W., Adams, D. H., Abraham, W. T., Kappetein, A. P., Généreux, P., Vranckx, P., Mehran, R., Kuck, K.-H., Leon, M. B., Piazza, N., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.049 · Cited by 594
Self-citationSecondary Mitral Regurgitation in Heart Failure
Asgar, A. W., Mack, M. J., & Stone, G. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.009 · Cited by 489
Self-citation
Research works printed but not linked: 1
- 16. cancer events. Biostatistics 2007; 8: 70821.
Cited by
Items 201–300 of 1,001
Recent successes in heart failure treatment
Lam, C. S. P., Docherty, K. F., Ho, J. E., McMurray, J. J. V., Myhre, P. L., & Omland, T. (2023) · Nature Medicine · doi:10.1038/s41591-023-02567-2 · Cited by 71
Kubo, S., Yamamoto, M., Saji, M., Asami, M., Enta, Y., Nakashima, M., Shirai, S., Izumo, M., Mizuno, S., Watanabe, Y., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030747 · Cited by 70
“6,13,14 Because these data suggest that MR reduction is directly re-lated to symptomatic improvement, the current patient selection in Japan seems appropriate.”
BackgroundMethodInfluential2025 ESC/EACTS Guidelines for the management of valvular heart disease
Praz, F., Borger, M. A., Lanz, J., Cuartas, M. M., Abreu, A., Adamo, M., Marsan, N. A., Barili, F., Bonaros, N. E., Cosyns, B., et al. (2025) · European Heart Journal - Valvular and Structural Heart Disease · doi:10.1093/ehjvshd/xwag001 · Cited by 73
Kanwar, M. K., Rajagopal, K., Itoh, A., Silvestry, S., Uriel, N. Y., Cleveland, J. C., Salerno, C. T., Horstmanshof, D., Goldstein, D. J., Naka, Y., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.003 · Cited by 70
Transcatheter Mitral Valve Replacement With the Transseptal EVOQUE System
Webb, J. G., Hensey, M., Fam, N., Rodés‐Cabau, J., Daniels, D. V., Smith, R. L., Szeto, W. Y., Boone, R. H., Ye, J., Moss, R., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.06.040 · Cited by 70
Self-citationGertz, Z. M., Herrmann, H. C., Lim, D. S., Kar, S., Kapadia, S. R., Reed, G. W., Puri, R., Krishnaswamy, A., Gersh, B. J., Weissman, N. J., et al. (2021) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.010300 · Cited by 69
Self-citationEffect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation
Halaby, R. N., Herrmann, H. C., Gertz, Z. M., Lim, S., Kar, S., Lindenfeld, J. M., Abraham, W. T., Grayburn, P. A., Naidu, S., Asch, F. M., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.01.049 · Cited by 69
Self-citationHausleiter, J., Lachmann, M., Stolz, L., Bedogni, F., Rubbio, A. P., Estévez‐Loureiro, R., Raposeiras‐Roubín, S., Boekstegers, P., Karam, N., Rudolph, V., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehad871 · Cited by 69
Benfari, G., Sorajja, P., Pedrazzini, G. B., Taramasso, M., Gavazzoni, M., Biasco, L., Essayagh, B. A., Grigioni, F., Bae, R. Y., Tribouilloy, C. M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab910 · Cited by 68
Bonow, R. O., O’Gara, P. T., Adams, D. H., Badhwar, V., Bavaria, J. E., Elmariah, S., Hung, J., Lindenfeld, J., Morris, A. A., Satpathy, R., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.002 · Cited by 68
Self-citationJCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 68
Estévez‐Loureiro, R., Shuvy, M., Taramasso, M., Benito‐González, T., Denti, P., Arzamendi, D., Adamo, M., Freixa, X., Villablanca, P. A., Krivoshei, L., et al. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29552 · Cited by 67
Percutaneous Repair of Secondary Mitral Regurgitation — A Tale of Two Trials
Nishimura, R. A., & Bonow, R. O. (2018) · New England Journal of Medicine · doi:10.1056/nejme1812279 · Cited by 62
Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary Mitral Regurgitation
Goel, K., Lindenfeld, J. M., Makkar, R., Naik, H., Atmakuri, S. R., Mahoney, P. D., Morse, M. A., Thourani, V. H., Yadav, P., Batchelor, W., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.07.015 · Cited by 66
Self-citationChinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024
ZHANG, S.-Y. (2025) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2025.03.002 · Cited by 70
Zweck, E., Spieker, M., Horn, P., Iliadis, C., Metze, C., Kavsur, R., Tiyerili, V., Nickenig, G., Baldus, S. E., Kelm, M., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.06.039 · Cited by 65
Lisko, J. C., Greenbaum, A. B., Guyton, R. A., Kamioka, N., Grubb, K. J., Gleason, P. T., Byku, I., Condado, J. F., Jadue, A., Paone, G., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.06.047 · Cited by 64
Müllens, W., Auricchio, A., Martens, P., Witte, K. K., Cowie, M., Delgado, V., Dickstein, K., Linde, C. M., Vernooy, K., Leyva, F., et al. (2021) · EP Europace · doi:10.1093/europace/euaa411 · Cited by 64
The need for increased pragmatism in cardiovascular clinical trials
Usman, M., Spall, H. G. C. V., Greene, S. J., Pandey, A., McGuire, D. K., Ali, Z. A., Mentz, R. J., Fonarow, G. C., Spertus, J. A., Anker, S. D., et al. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00705-w · Cited by 65
Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial
Kang, D., Park, S., Shin, S., Hwang, I., Yoon, Y. E., Kim, H., Kim, M., Kim, M., Yun, S., Song, J., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.069144 · Cited by 65
von Bardeleben, R. S., Hobohm, L., Kreidel, F., Ostad, M. A., Schulz, E., Konstantinides, S., Lankeit, M., Feldman, T. E., Münzel, T. F., & Keller, K. (2019) · EuroIntervention · doi:10.4244/eij-d-18-00961 · Cited by 64
Orban, M., Karam, N., Lubos, E., Kalbacher, D., Braun, D., Deseive, S., Neuß, M., Butter, C., Praz, F., Kassar, M., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.05.042 · Cited by 64
NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure
Giustino, G., Lindenfeld, J. M., Abraham, W. T., Kar, S., Lim, D. S., Grayburn, P. A., Kapadia, S. R., Cohen, D. J., Kotinkaduwa, L. N., Weissman, N. J., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.06.058 · Cited by 64
Self-citationPrevalence and Prognostic Significance of Mitral Regurgitation in Acute Decompensated Heart Failure
Arora, S., Sivaraj, K., Hendrickson, M. J., Chang, P. P., Weickert, T., Qamar, A., Vaduganathan, M., Caughey, M. C., Pandey, A., Cavender, M. A., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2020.09.015 · Cited by 63
“The COAPT trial (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation) recently reported improved mortality in HF patients with severe secondary MR receiving transcatheter mitral valve repair as opposed to medical therapy alone (21).”
MethodBenfari, G., Essayagh, B. A., Nistri, S., Maalouf, J., Rossi, A., Thapa, P. B., Michelena, H. I., & Enriquez-Sarano, M. L. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.011608 · Cited by 64
Yoon, S., Makar, M. M., Kar, S., Chakravarty, T., Oakley, L. S., Sekhon, N., Koseki, K., Nakamura, M., Hamilton, M. A., Patel, J. K., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.07.004 · Cited by 62
Self-citationSecondary Mitral Regurgitation: Cardiac Remodeling, Diagnosis, and Management
Huang, A. L., Dal‐Bianco, J. P., Levine, R. A., & Hung, J. (2022) · Structural Heart · doi:10.1016/j.shj.2022.100129 · Cited by 62
Chang, C. C., Veen, K. M., Hahn, R. T., Bogers, A. J. J. C., Latib, A., Oei, F. B. S., Abdelghani, M., Modolo, R., Ho, S. Y., Abdel‐Wahab, M., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz614 · Cited by 62
“two clinical outcome trials, MITRA-FR and COAPT were published.(93,94) Both trials randomly assigned patients with FMR to”
MethodAdamo, M., Inciardi, R. M., Tomasoni, D., Dallapellegrina, L., Estévez‐Loureiro, R., Stolfo, D., Lupi, L., Pancaldi, E., Rubbio, A. P., Giannini, C., et al. (2022) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2022.08.012 · Cited by 61
The Aging Heart: A Molecular and Clinical Challenge
Lazzeroni, D., Villatore, A., Souryal, G., Pili, G., & Peretto, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416033 · Cited by 62
Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment
Curio, J., Demir, O. M., Pagnesi, M., Mangieri, A., Giannini, F., Weisz, G., & Latib, A. (2019) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2019.5.1 · Cited by 61
Aimo, A., Vergaro, G., González, A., Barison, A., Lupón, J., Delgado, V., Richards, M., de Boer, R. A., Thum, T., Arfsten, H., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2522 · Cited by 60
Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías
Vahanian, A. S., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S. E., Bauersachs, J. K., Capodanno, D., Conradi, L., Bonis, M. D., Paulis, R. D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.023 · Cited by 61
Little, S. H., Rigolin, V. H., Garcia-Sayan, E. D., Hahn, R. T., Hung, J., Mackensen, G. B., Mankad, S. V., Quader, N., & Sarić, M. (2023) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2023.01.014 · Cited by 60
“The current ACC/AHA guideline for the management of patients with valvular heart disease(20) gives mitral TEER repair a class IIa level of recommendation for patients at high surgical risk with primary mitral regurgitation (MR) and patients with secondary MR who fulfill the COAPT (Cardiovascular Outcomes Assessment of…”
MethodHeart failure management guidelines: New recommendations and implementation
Heidenreich, P. A. (2023) · Journal of Cardiology · doi:10.1016/j.jjcc.2023.10.009 · Cited by 60
Treatment options for ischemic mitral regurgitation: A meta-analysis
Nappi, F., Antoniou, G. A., Nenna, A., Michler, R. E., Benedetto, U., Singh, S., Gambardella, I., & Chello, M. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.05.041 · Cited by 61
Sodhi, N., Asch, F. M., Ruf, T. F., Petrescu, A. M., von Bardeleben, R. S., Lim, D. S., Maisano, F., Kar, S., & Price, M. J. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.07.023 · Cited by 59
Self-citationRecurrent Events in Cardiovascular Trials
Gregson, J., Stone, G. W., Bhatt, D. L., Packer, M., Anker, S. D., Zeller, C., Redfors, B., & Pocock, S. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.07.024 · Cited by 60
Self-citationTrends in MitraClip, mitral valve repair, and mitral valve replacement from 2000 to 2016
Zhou, S., Egorova, N., Moskowitz, G., Giustino, G., Ailawadi, G., Acker, M. A., Gillinov, M., Moskowitz, A. J., & Gelijns, A. C. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.12.097 · Cited by 59
Fleury, M.-A., & Clavel, M.-A. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.02.003 · Cited by 58
Masuda, M., Sekiya, K., Asai, M., Iida, O., Okamoto, S., Ishihara, T., Nanto, K., Kanda, T., Tsujimura, T., Matsuda, Y., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13896 · Cited by 58
“The beneficial impact of MR reduction on long-term prognosis was supported by the results of the randomized controlled COAPT trial, which reported a better heart failure prognosis in patients undergoing percutaneous mitral valve repair than those without.(15)”
ResultGuideline directed medical therapy and reduction of secondary mitral regurgitation
Spinka, G., Bartko, P. E., Heitzinger, G., Prausmüller, S., Winter, M., Arfsten, H., Strunk, G., Rosenhek, R., Kastl, S., Hengstenberg, C., et al. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac068 · Cited by 58
Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure
Giustino, G., Camaj, A., Kapadia, S. R., Kar, S., Abraham, W. T., Lindenfeld, J. M., Lim, D. S., Grayburn, P. A., Cohen, D. J., Redfors, B., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.803 · Cited by 58
Self-citationTrends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020
Tan, M. C., Yeo, Y. H., San, B. J., Suleiman, A., Lee, J. Z., Chatterjee, A., Sell‐Dottin, K. A., Sweeney, J. P., Fortuin, F. D., & Lee, K. S. S. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.030895 · Cited by 58
Mitral Valve Surgery After Transcatheter Edge-to-Edge Repair
Kaneko, T., Hirji, S. A., Zaid, S., Lange, R., Kempfert, J., Conradi, L., Hagl, C. M., Borger, M. A., Taramasso, M., Nguyen, T. C., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.07.029 · Cited by 58
Self-citationRubbio, A. P., Testa, L., Grasso, C., Sisinni, A., Tusa, M. B., Agricola, E., MARCO, F. D., Petronio, A. S., Montorfano, M., Citro, R., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.11.027 · Cited by 58
Guerrero, M. E., Daniels, D. V., Makkar, R., Thourani, V. H., Asch, F. M., Pham, M., Muhammad, K. I., Greenbaum, A. B., Vásquez, A. A., Oldemeyer, J. B., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)02073-2 · Cited by 57
Self-citationKoell, B., Ludwig, S., Weimann, J., Waldschmidt, L., Hildebrandt, A., Schofer, N., Schirmer, J. M., Westermann, D., Reichenspurner, H. C., Blankenberg, S., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.12.007 · Cited by 57
Transcatheter Edge-to-Edge Repair for Atrial Secondary Mitral Regurgitation
Tanaka, T., Sugiura, A., Öztürk, C., Vogelhuber, J., Tabata, N., Wilde, N., Zimmer, S., Nickenig, G., & Weber, M. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.06.005 · Cited by 57
Left Ventricular Reverse Remodelling and Its Predictors in Non-Ischaemic Cardiomyopathy
Hnát, T., Veselka, J., & Honěk, J. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13939 · Cited by 56
MitraClip and Left Ventricular Reverse Remodelling: A Strain Imaging Study
Papadopoulos, K. G., Ikonomidis, I., Chrissoheris, M. P., Chalapas, A., Kourkoveli, P., Parissis, J., & Spargias, K. S. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12750 · Cited by 56
An updated meta-analysis of MitraClip versus surgery for mitral regurgitation
Oh, N. A., Kampaktsis, P. Ν., Gallo, M., Guariento, A., Weixler, V. H.-M., Staffa, S. J., Avgerinos, D. V., Colli, A., & Doulamis, I. P. (2021) · Annals of Cardiothoracic Surgery · doi:10.21037/acs-2020-mv-24 · Cited by 56
Transcatheter Mitral Valve Implantation: Current Status and Future Perspectives
Russo, G., Gennari, M., Gavazzoni, M., Pedicino, D., Pozzoli, A., Taramasso, M., & Maisano, F. (2021) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.121.010628 · Cited by 56
Sex-Related Factors in Valvular Heart Disease
Hahn, R. T., Clavel, M.-A., Mascherbauer, J., Mick, S. L., Asgar, A. W., & Douglas, P. S. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.08.081 · Cited by 55
Multimodality imaging in ischaemic heart failure
Bax, J. J., Carli, M. F. D., Narula, J., & Delgado, V. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33207-0 · Cited by 55
Atrial functional versus ventricular functional mitral regurgitation: Prognostic implications
Hirji, S. A., Cote, C. L., Javadikasgari, H., Malarczyk, A. A., McGurk, S., & Kaneko, T. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.12.098 · Cited by 55
Hagendorff, A., Knebel, F., Helfen, A., Stöbe, S., Haghi, D., Ruf, T. F., Lavall, D., Knierim, J., Altiok, E., Brandt, R. R., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01841-y · Cited by 55
Left Atrial Reservoir Function and Outcomes in Secondary Mitral Regurgitation
Stassen, J., Namazi, F., van der Bijl, P., van Wijngaarden, S. E., Kamperidis, V., Marsan, N. A., Delgado, V., & Bax, J. J. (2022) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2022.01.007 · Cited by 55
Expanding the Spectrum of TEER Suitability
Rogers, J. H., Asch, F. M., Sorajja, P., Mahoney, P. D., Price, M. J., Maisano, F., Denti, P., Morse, M. A., Rinaldi, M., Bedogni, F., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.05.014 · Cited by 55
Self-citationPonikowski, P. P., Friede, T., von Bardeleben, R. S., Butler, J., Khan, M. S., Diek, M., Heinrich, J., Geyer, M., Placzek, M., Ferrari, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.08.027 · Cited by 55
Self-citationComplications Following Percutaneous Mitral Valve Repair
Gheorghe, L. L., Ielasi, A., Rensing, B. J. W. M., Eefting, F. D., Timmers, L., Latib, A., & Swaans, M. J. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00146 · Cited by 55
“Except for a mitral valve orifice area (MVOA) 4 cm2 in COAPT, no specific anatomic exclusion criteria are applied in the most recent randomized trials, MITRA-FR (9) and COAPT (5).”
BackgroundMethodInfluentialMessika–Zeitoun, D., Candolfi, P., Vahanian, A. S., Chan, V., Burwash, I. G., Philippon, J.-F., Toussaint, J.-M., Verta, P., Feldman, T. E., Iung, B., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016086 · Cited by 55
“25,26 Similar high event rates were observed in 2 recent randomized controlled trials comparing the Mitraclip system with optimal medical therapy in 1000 patients with SMR. 6,9 In our study, even PMR was associated with high event rates, especially in patients with HF at presentation.”
Predictors of Outcomes Following Transcatheter Edge-to-Edge Mitral Valve Repair
Ben‐Shoshan, J., Overtchook, P., Buithieu, J., Mousavi, N., Martucci, G. J., Spaziano, M., de Varennes, B., Lachapelle, K. J., Brophy, J. M., Modine, T., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.03.025 · Cited by 55
Prognostic Role of TAPSE to PASP Ratio in Patients Undergoing MitraClip Procedure
Trejo‐Velasco, B., Estévez‐Loureiro, R., Carrasco‐Chinchilla, F., Fernández‐Vázquez, F., Arzamendi, D., Pan, M., Pascual, I., y, L. N.-F., Amat-Santos, I. J., Freixa, X., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051006 · Cited by 55
Tsigkas, G., Apostolos, A., Despotopoulos, S., Vasilagkos, G., Kallergis, E. M., Leventopoulos, G., Mplani, V., & Davlouros, P. A. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10133-6 · Cited by 56
Doldi, P. M., Stolz, L., Kalbacher, D., Koell, B., Geyer, M., Ludwig, S., Orban, M., Braun, D., Weckbach, L. T., Stocker, T. J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2661 · Cited by 54
The Evolving Concept of Secondary Mitral Regurgitation Phenotypes
Stolz, L., Doldi, P. M., Sannino, A., Hausleiter, J., & Grayburn, P. A. (2024) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2024.01.012 · Cited by 54
Self-citationSadeghpour, A., Jiang, Z., Hummel, Y. M., Frost, M., Lam, C. S. P., Shah, S. J., Lund, L. H., Stone, G. W., Swaminathan, M., Weissman, N. J., et al. (2024) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2024.06.011 · Cited by 54
Self-citationVandenbriele, C., Balthazar, T., WILSON, J. G., Adriaenssens, T., Davies, S., Droogné, W., Dubois, C., Caetano, A. F. S., Goetschalckx, K., Jacobs, S., et al. (2020) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuaa031 · Cited by 54
Principal Morphomic and Functional Components of Secondary Mitral Regurgitation
Bartko, P. E., Heitzinger, G., Spinka, G., Pávó, N., Prausmüller, S., Kastl, S., Winter, M., Arfsten, H., Tan, T. C., Gebhard, C., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.05.020 · Cited by 54
Chronological vs Biological Age in Interventional Cardiology
Damluji, A. A., Nanna, M. G., Rymer, J., Kochar, A., Lowenstern, A., Baron, S. J., Narins, C. R., & Alkhouli, M. (2024) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2024.01.284 · Cited by 53
Valvular Heart Disease: New Concepts in Pathophysiology and Therapeutic Approaches
Eleid, M. F., Nkomo, V. T., Pislaru, S. V., & Gersh, B. J. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-122533 · Cited by 53
Burden of Undiagnosed Valvular Heart Disease in the Elderly in the Community
Gössl, M., Stanberry, L. I., Benson, G. A., Steele, E., Garberich, R., Witt, D., Cavalcante, J. L., Sharkey, S. W., & Enriquez-Sarano, M. L. (2023) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2023.02.009 · Cited by 53
Agricola, E., Ancona, F., Bartel, T., Brochet, É., Dweck, M. R., Faletra, F. F., Lancellotti, P., Mahmoud-Elsayed, H. M., Marsan, N. A., Maurovich‐Horvat, P., et al. (2023) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jead096 · Cited by 53
Mitral regurgitation in heart failure: time for a rethink
Praz, F., Grasso, C., Taramasso, M., Baumbach, A., Piazza, N., Tamburino, C., Windecker, S., Maisano, F., & Prendergast, B. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz222 · Cited by 53
Gender-specific differences in valvular heart disease
Nitsche, C., Koschutnik, M., Kammerlander, A. A., Hengstenberg, C., & Mascherbauer, J. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-01603-x · Cited by 53
Adamo, M., Cani, D., Gavazzoni, M., Taramasso, M., Lupi, L., Fiorelli, F., Giannini, C., Branca, L., Züber, M., Curello, S., et al. (2020) · EuroIntervention · doi:10.4244/eij-d-19-01114 · Cited by 53
Lindman, B. R., Arnold, S. V., Bagur, R., Clarke, L., Coylewright, M., Evans, F., Hung, J., Lauck, S. B., Peschin, S., Sachdev, V., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015975 · Cited by 51
Concomitant Mitral Regurgitation in Patients With Chronic Aortic Regurgitation
Yang, L., Enriquez-Sarano, M. L., Scott, C. G., Padang, R., Maalouf, J. F., Pellikka, P. A., & Michelena, H. I. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.051 · Cited by 53
Benito‐González, T., Carrasco‐Chinchilla, F., Estévez‐Loureiro, R., Pascual, I., Arzamendi, D., Garrote‐Coloma, C., y, L. N.-F., Pan, M., Serrador, A., Freixa, X., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.09.056 · Cited by 53
Ojeda, S., Romaguera, R., Cruz‐González, I., & Moreno, R. (2020) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.07.024 · Cited by 52
A Year in Heart Failure: An Update of Recent Findings
Stretti, L., Zippo, D., Coats, A. J. S., Anker, M. S., von Haehling, S., Metra, M., & Tomasoni, D. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13760 · Cited by 52
“trial demonstrated a significant reduction in 2 year HF hospitalization and all-cause mortality.(176) Different outcomes”
BackgroundJanuzzi, J. L., Omar, A. M. S., Liu, Y., Murphy, S., Butler, J., Felker, G. M., Piña, I. L., Ward, J. H., Solomon, S. D., & Contreras, J. (2022) · Circulation · doi:10.1161/circulationaha.122.061693 · Cited by 52
Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation
Scotti, A., Coisne, A., Granada, J. F., Driggin, E., Madhavan, M. V., Zhou, Z., Redfors, B., Kar, S., Lim, D. S., Cohen, D. J., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.047 · Cited by 51
Self-citationTranscatheter Interventions for Mitral Regurgitation
Bax, J. J., Debonnaire, P., Lancellotti, P., Ajmone Marsan, N., Tops, L. F., Min, J. K., Piazza, N., Leipsic, J., Hahn, R. T., & Delgado, V. (2019) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2019.03.036 · Cited by 47
Rosano, G. M. C., Stolfo, D., Anderson, L., Abdelhamid, M., Adamo, M., Bauersachs, J., Bayés‐Genís, A., Böhm, M., Chioncel, O. D., Filippatos, G. S., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3284 · Cited by 51
Management of valvulopathies with acute severe heart failure and cardiogenic shock
Akodad, M., Schurtz, G., Adda, J., Leclercq, F., & Roubille, F. (2019) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2019.06.009 · Cited by 50
“Recently, the device has been studied in secondary MR, with favourable results in terms of mortality and hospitalization for heart failure compared with optimal medical treatment in the COAPT trial, but not in the MITRA-FR trial [17,30].”
BackgroundResultRecovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management
Chang, H., Chen, K.-C., Fong, M.-C., Feng, A.-N., Fu, H., Huang, K., Chong, E. Y., & Yin, W. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.08.005 · Cited by 50
Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024
Chinese Society of Cardiology, C. M. A., Chinese College of Cardiovascular Physician, Chinese Heart Failure Association of Chinese Medical Doctor Association, & Editorial Board of Chinese Journal of Cardiology (2025) · Cardiology Discovery · doi:10.1097/cd9.0000000000000146 · Cited by 50
Pulmonary hypertension and valvular heart disease
Tichelbäcker, T., Dumitrescu, D., Gerhardt, F., Stern, D., Wißmüller, M., Adam, M., Schmidt, T., Frerker, C., Pfister, R., Halbach, M., et al. (2019) · Herz · doi:10.1007/s00059-019-4823-6 · Cited by 49
JCS/JHFS 2021 Statement on Palliative Care in Cardiovascular Diseases
Anzai, T., Sato, T., Fukumoto, Y., Izumi, C., Kizawa, Y., Koga, M., Nishimura, K., Ohishi, M., Sakashita, A., Sakata, Y., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-1127 · Cited by 49
O’Gara, P. T., Lindenfeld, J. M., Hahn, R. T., Joseph, M., Khalique, O. K., Khazanie, P., Kumbhani, D. J., Page, R. L., II, Patton, K. K., & Thourani, V. H. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.07.002 · Cited by 48
Self-citationKosmidou, I., Lindenfeld, J., Abraham, W. T., Rinaldi, M., Kapadia, S. R., Rajagopal, V., Sarembock, I. J., Brieke, A., Gaba, P., Rogers, J. H., et al. (2021) · JACC Heart Failure · doi:10.1016/j.jchf.2021.04.011 · Cited by 48
Self-citationGaasch, W. H., Aurigemma, G. P., & Meyer, T. E. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2019.5980 · Cited by 47
Geyer, M., Keller, K., Bachmann, K., Born, S., Tamm, A., Ruf, T. F., Kreidel, F., Hahad, O., Petrescu, A. M., Hell, M. M., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01798-4 · Cited by 47
Soluble ST2 – a new biomarker in heart failure
Biaggi, P., Ammann, C., Imperiali, M., Hammerer‐Lercher, A., Breidthardt, T., Mueller, C. E., Maisel, A. S., & Ruschitzka, F. T. (2019) · Cardiovascular Medicine · doi:10.4414/cvm.2019.02008 · Cited by 46
The economics of heart failure care
Chen, W., Heidenreich, P. A., & Sandhu, A. T. (2024) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2024.01.010 · Cited by 46
Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation
Stocker, T. J., Stolz, L., Karam, N., Kalbacher, D., Koell, B., Trenkwalder, T., Xhepa, E., Adamo, M., Spieker, M., Horn, P., et al. (2024) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2024.08.016 · Cited by 46
Caballero, A., Mao, W., McKay, R. G., Hahn, R. T., & Sun, W. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00432 · Cited by 46
Hernández-Suárez, D. F., Ranka, S., Kim, Y., Latib, A., Wiley, J. M., López‐Candales, A., Pinto, D. S., Gonzalez, M., Ramakrishna, H., Sanina, C., et al. (2020) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2020.06.017 · Cited by 46
“With the recent expansion of TMVR indications to include patients with heart failure and moderate to severe or severe secondary MR [4], it is expected that TMVR utilization will undoubtedly become a therapeutic option for many other patients.”
Background
Metadata
- Authors
- Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., Rajagopal, V., Sarembock, I. J., Brieke, A., Marx, S. O., Cohen, D. J., Weissman, N. J., & Mack, M. J.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Cedars-Sinai Medical Center (US)
- Cleveland Clinic (US)
- University of Colorado Hospital (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-12-13
- Volume
- 379
- Issue
- 24
- Pages
- 2307-2318
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2889688444
- Cited by
- 3,017
- References
- 23
- Citations by year
- 2026: 253 · 2025: 330 · 2024: 308 · 2023: 372 · 2022: 385 · 2021: 486 · 2020: 453 · 2019: 376 · 2018: 42
- FWCI
- 256.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Abbott
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Surgery › Cardiac Structural Anomalies and Repair
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- transcatheter mitral valve repair, heart failure, functional mitral regurgitation, left ventricular dysfunction, heart failure hospitalization, all-cause mortality, device complications, guideline-directed medical therapy, COAPT trial, transcatheter edge-to-edge repair, mitral valve repair, transcatheter closure devices, transcatheter aortic valve implantation, transcatheter mitral valve replacement
- MeSH terms
- Aged, Aged, 80 and over, Combined Modality Therapy, Female, Heart Failure, Heart Valve Prosthesis, Hospitalization, Humans, Male, Middle Aged, Mitral Valve, Mitral Valve Insufficiency, Prosthesis Failure, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left, Heart Valve Prosthesis Implantation, Kaplan-Meier Estimate, Intention to Treat Analysis, Percutaneous Coronary Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.